Kumanan Wilson1, Steven Hawken2, Robin Ducharme2, Beth K Potter2, Julian Little3, Bernard Thébaud4, Pranesh Chakraborty5. 1. 1] Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada [2] Institute for Clinical Evaluative Sciences, University of Ottawa, Ottawa, Ontario, Canada [3] Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 2. 1] Institute for Clinical Evaluative Sciences, University of Ottawa, Ottawa, Ontario, Canada [2] Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada [3] Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. 3. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. 4. 1] Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada [2] Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada [3] Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. 5. 1] Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada [2] Newborn Screening Ontario, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Abstract
BACKGROUND: Prematurity may influence the levels of amino acids, enzymes, and endocrine markers obtained through newborn screening. Identifying which analytes are the most affected by degree of prematurity could provide insight into how prematurity impacts metabolism. METHODS: Analytes from blood spots assayed by Newborn Screening Ontario between March 2006 and April 2009 were used in this analysis. We examined the associations between the degree of prematurity and the levels of amino acids, enzymes, and endocrine markers in all newborns with and without adjustment for birth weight, feeding status, sample timing, transfusion, and sex. RESULTS: Our analysis included the following cohorts: 373,819 children born at term (>36 wk gestation), 26,483 near-term children (33-36 wk gestation), 4,354 very premature children (28-32 wk gestation), and 1,146 extremely premature children (<28 wk gestation). Of the amino acids showing consistent trends across categories of prematurity, the levels of three amino acids (arginine, leucine, and valine) were at least 50% different between the cohorts of extremely premature and term children. The levels of 17-hydroxyprogesterone increased with increasing prematurity, while thyrotropin-stimulating hormone values consistently decreased with increasing prematurity. None of the three enzyme markers we examined showed a trend in levels across categories of prematurity. CONCLUSION: This study demonstrates that children at different stages of prematurity are metabolically distinct. Future research should focus on the mechanism by which specific analytes are influenced by prematurity.
BACKGROUND: Prematurity may influence the levels of amino acids, enzymes, and endocrine markers obtained through newborn screening. Identifying which analytes are the most affected by degree of prematurity could provide insight into how prematurity impacts metabolism. METHODS: Analytes from blood spots assayed by Newborn Screening Ontario between March 2006 and April 2009 were used in this analysis. We examined the associations between the degree of prematurity and the levels of amino acids, enzymes, and endocrine markers in all newborns with and without adjustment for birth weight, feeding status, sample timing, transfusion, and sex. RESULTS: Our analysis included the following cohorts: 373,819 children born at term (>36 wk gestation), 26,483 near-term children (33-36 wk gestation), 4,354 very premature children (28-32 wk gestation), and 1,146 extremely premature children (<28 wk gestation). Of the amino acids showing consistent trends across categories of prematurity, the levels of three amino acids (arginine, leucine, and valine) were at least 50% different between the cohorts of extremely premature and term children. The levels of 17-hydroxyprogesterone increased with increasing prematurity, while thyrotropin-stimulating hormone values consistently decreased with increasing prematurity. None of the three enzyme markers we examined showed a trend in levels across categories of prematurity. CONCLUSION: This study demonstrates that children at different stages of prematurity are metabolically distinct. Future research should focus on the mechanism by which specific analytes are influenced by prematurity.
Authors: Madeleine Ernst; Simon Rogers; Ulrik Lausten-Thomsen; Anders Björkbom; Susan Svane Laursen; Julie Courraud; Anders Børglum; Merete Nordentoft; Thomas Werge; Preben Bo Mortensen; David M Hougaard; Arieh S Cohen Journal: Pediatr Res Date: 2020-09-17 Impact factor: 3.756
Authors: Scott P Oltman; Elizabeth E Rogers; Rebecca J Baer; Elizabeth A Jasper; James G Anderson; Martina A Steurer; Matthew S Pantell; Mark A Petersen; J Colin Partridge; Deborah Karasek; Kharah M Ross; Sky K Feuer; Linda S Franck; Larry Rand; John M Dagle; Kelli K Ryckman; Laura L Jelliffe-Pawlowski Journal: Pediatr Res Date: 2020-10-01 Impact factor: 3.756
Authors: Ellis Voerman; Vincent W V Jaddoe; Engy Shokry; George J G Ruijter; Janine F Felix; Berthold Koletzko; Romy Gaillard Journal: Pediatr Obes Date: 2021-08-12 Impact factor: 3.910
Authors: Deshayne B Fell; Steven Hawken; Coralie A Wong; Lindsay A Wilson; Malia S Q Murphy; Pranesh Chakraborty; Thierry Lacaze-Masmonteil; Beth K Potter; Kumanan Wilson Journal: Sci Rep Date: 2017-12-21 Impact factor: 4.379
Authors: Sarah Jane Metrustry; Ville Karhunen; Mark H Edwards; Cristina Menni; Thomas Geisendorfer; Anja Huber; Christian Reichel; Elaine M Dennison; Cyrus Cooper; Tim Spector; Marjo-Riitta Jarvelin; Ana M Valdes Journal: PLoS One Date: 2018-03-22 Impact factor: 3.240